Skip to main content
SpringerLink
Log in

FDA conducts safety review of Singulair

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. FDA.Early Communication About an Ongoing Safety Review of Montelukast (Singulair). Media Release: 27 Mar 2008. Available from: URL: http://www.fda.gov

  2. American College of Allergy, Asthma & Immunology, American Academy of Allergy Asthma & Immunology.Joint statement on FDA investigation of Singulair from the ACAAI and AAAAI. Media Release: 28 Mar 2008. Available from: URL: http://www.acaai.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

FDA conducts safety review of Singulair. React. Wkly. 1196, 2 (2008). https://doi.org/10.2165/00128415-200811960-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200811960-00003

Keywords

Search

Navigation